Patients With Diabetes Without Significant Angiographic Coronary Artery Disease Have the Same Risk of Myocardial Infarction as Patients Without Diabetes in a Real-World Population Receiving Appropriate Prophylactic Treatment
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The risk of myocardial infarction (MI) in patients with diabetes is greater than for patients without diabetes. Consequently, prophylactic treatment is recommended for patients with diabetes and risk factors for ischemic heart disease. We aimed to estimate the risk of adverse cardiac events in patients with and without diabetes with and without coronary artery disease (CAD) after coronary angiography (CAG). RESEARCH DESIGN AND METHODS: A population-based cohort of patients registered in the Western Denmark Heart Registry who underwent CAG between 1 January 2003 and 31 December 2012 was stratified according to the presence or absence of obstructive CAD and diabetes. End points were death, cardiac death, and MI. Unadjusted and adjusted rate ratios (RRs) were calculated by using patients without diabetes and without CAD as the reference group. RESULTS: We included 93,866 patients of whom 12,544 (13.4%) had diabetes at the time of CAG. Median follow-up was 4.1 years. Patients with and without diabetes without obstructive CAD had the same adjusted risk of death (RR 1.03 [95% CI 0.92–1.15]), cardiac death (RR 1.21 [95% CI 0.90–1.64]), and MI (RR 0.88 [95% CI 0.65–1.17]). Patients with diabetes without CAD were more often treated with statins (75.3% vs. 46.0%) and aspirin (65.7% vs. 52.7%) than patients without diabetes and CAD. CONCLUSIONS: In a real-world population, patients with diabetes with high rates of statin and aspirin treatment had the same risk of cardiovascular events as patients without diabetes in the absence of angiographically significant CAD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A gain-of-function mutation in apoC3 that leads to high ApoC-III levels can also cause severe HTG by inhibiting the activity of LPL”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [380]
In the citing paper
“whereas loss-of-function mutations are associated with a favourable lipid profile with low TG levels [380].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [380]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742 · cited 1×
“Comorbidity The Charlson comorbidity index score was estimated for each patient on the CAG date (17).”
MethodDetection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
Zou, G. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh090 · Cited by 9,615
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081 · cited 1×
“Statin treatment has similarly been associated with a significant reduction of coronary events in patients with diabetes (29,30).”
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes
Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., Arima, H., Monaghan, H., Joshi, R., Colagiuri, S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407963 · Cited by 626
Hu, F. B., Stampfer, M. J., Solomon, C. G., Liu, S., Willett, W. C., Speizer, F. E., Nathan, D. M., & Manson, J. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.14.1717 · Cited by 534
The Danish registers of causes of death.
Juel, K., & Helweg‐Larsen, K. (1999) · PubMed · Cited by 411
Evans, J. M. M., Wang, J., & Morris, A. D. (2002) · BMJ · doi:10.1136/bmj.324.7343.939 · Cited by 392
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000230 · Cited by 386
Johannesdottir, S. A., Horváth-Puhó, E., Ehrenstein, V., Schmidt, Pedersen, L., & Sørensen, H. (2012) · Clinical Epidemiology · doi:10.2147/clep.s37587 · Cited by 379 · cited 3×
“Records of treatmentwith statin (Anatomical Therapeutic Chemical [ATC] codes C10AA01–05, C10AA07), aspirin (ATC codes B01AC06, N02BA01), ACE inhibitor/ angiotensin II receptor blocker (ARB) (ATC codes C09AA01–06, C09AA10, C09CA01, C09CA03–04, C09CA06–08), and b-blocker (ATC codes C07AA–AB) were obtained through the Da…”
MethodInfluentialSelf-citationIs diabetes a coronary risk equivalent? Systematic review and meta‐analysis
Bulugahapitiya, U., Siyambalapitiya, S., Sithole, J., & Idris, I. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02640.x · Cited by 377 · cited 1×
“without diabetes with prior MI yielded a 44% lower risk ofMI in the diabetes group (24).”
BackgroundLee, C. D., Folsom, A. R., Pankow, J. S., & Brancati, F. L. (2004) · Circulation · doi:10.1161/01.cir.0000116389.61864.de · Cited by 276
The Task Force on diabetes, P.-D. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114525548 · Cited by 236
Cho, E., Rimm, E. B., Stampfer, M. J., Willett, W. C., & Hu, F. B. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02044-2 · Cited by 225
9. Cardiovascular Disease and Risk Management
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc17-s012 · Cited by 223
Diabetes and All-Cause and Coronary Heart Disease Mortality Among US Male Physicians
Lotufo, P. A., Gaziano, J. M., Chae, C. U., Ajani, U. A., Moreno-John, G., Buring, J. E., & Manson, J. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.2.242 · Cited by 219
Malik, S., Budoff, M. J., Katz, R., Blumenthal, R. S., Bertoni, A. G., Nasir, K., Szklo, M., Barr, R. G., & Wong, N. D. (2011) · Diabetes Care · doi:10.2337/dc11-0816 · Cited by 205
Existing data sources for clinical epidemiology: The Western Denmark Heart Registry
Schmidt, M. (2010) · Clinical Epidemiology · doi:10.2147/clep.s10190 · Cited by 165
Self-citationNicholls, S. J., Tuzcu, E. M., Crowe, T., Sipahi, İ., Schoenhagen, P., Kapadia, S. R., Hazen, S. L., Wun, C., Norton, M., Ntanios, F. Y., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.12.058 · Cited by 150 · cited 1×
“(22) found that diabetes was among one of the strongest predictors of atherosclerotic burden in patients with established CAD.”
BackgroundImpact of Incident Diabetes and Incident Nonfatal Cardiovascular Disease on 18-Year Mortality
Eberly, L. E., Cohen, J. D., Prineas, R., Yang, L., & For The Multiple Risk Factor Intervention Trial Research Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.848 · Cited by 149
Wannamethee, S. G., Shaper, A. G., & Lennon, L. (2004) · Heart · doi:10.1136/hrt.2003.026104 · Cited by 114
Saely, C. H., Aczél, S., Marte, T., Langer, P. H., & Drexel, H. (2004) · Diabetologia · doi:10.1007/s00125-003-1274-6 · Cited by 77
Hu, G., Jousilahti, P., Qiao, Q., Peltonen, M., Katoh, S., & Tuomilehto, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.039 · Cited by 76
Jensen, L. O., Thayssen, P., Junker, A., Mæng, M., Tilsted, H., Kaltoft, A., Hansen, K. N., Christiansen, E. H., Kristensen, S. D., Ravkilde, J., et al. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.022 · Cited by 53 · cited 1×
“That diabetes approximately doubles the risk of MI and death among patients with known CAD is well-known (20,21).”
BackgroundSelf-citationEgholm, G., Madsen, M., Thim, T., Schmidt, M., Christiansen, E. H., Bøtker, H. E., & Mæng, M. (2016) · Clinical Epidemiology · doi:10.2147/clep.s108906 · Cited by 43 · cited 1×
“Beyond 30 days, the sensitivity and specificity of the MI diagnosis was 94% and 98%, respectively (18).”
Self-citationOlesen, K. K. W., Tilsted, H., Jensen, L. O., Kaltoft, A., Krusell, L. R., Ravkilde, J., Christiansen, E. H., Madsen, M., Thayssen, P., Sørensen, H. T., et al. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.10.038 · Cited by 19
Self-citationMortality Associated with Diabetes and Cardiovascular Disease in Older Women
Nanchen, D., Rodondi, N., Cornuz, J., Hillier, T. A., Ensrud, K. E., Cauley, J. A., & Bauer, D. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048818 · Cited by 7
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
“Recent data indicate that DM per se increases CVD risk about two-fold on average, but the risk is subject to wide variation depending on the population and current aggressive prophylactic therapy.(401,404) Importantly, those with DM and CAD are at substantially higher CVD risk for future events.”
Diabetes Mellitus–Related All‐Cause and Cardiovascular Mortality in a National Cohort of Adults
Raghavan, S., Vassy, J. L., Ho, Y., Song, R. J., Gagnon, D. R., Cho, K., Wilson, P. W. F., & Phillips, L. S. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011295 · Cited by 563
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Banach, M., Burchardt, P., Chlebus, K., Dobrowolski, P., Dudek, D., Dyrbuś, K., Gąsior, M., Jankowski, P., Jozwiak, J. J., Kłosiewicz−Latoszek, L., et al. (2021) · Archives of Medical Science · doi:10.5114/aoms/141941 · Cited by 186
The Western Denmark Heart Registry
Schmidt, M., Mæng, M., Madsen, M., Sørensen, H. T., Jensen, L. O., & Jakobsen, C.-J. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.110 · Cited by 148
Self-citation
Metadata
- Authors
- Olesen, K. K. W., Madsen, M., Egholm, G., Thim, T., Jensen, L. O., Raungaard, B., Bøtker, H. E., Sørensen, H. T., & Maeng, M.
- Affiliations
- Aarhus University Hospital (DK)
- Odense University Hospital (DK)
- Aalborg University Hospital (DK)
- Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2017-06-08
- Volume
- 40
- Issue
- 8
- Pages
- 1103-1110
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2621500879
- Cited by
- 51
- References
- 32
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 1 · 2022: 5 · 2021: 11 · 2020: 7 · 2019: 15 · 2018: 2 · 2017: 2
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Funders
- Hjerteforeningen (14-R97-A5144-22860)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- diabetes mellitus, myocardial infarction, coronary artery disease, coronary angiography, statins, aspirin, secondary prevention, cardiovascular risk, cardiovascular mortality, ischemic heart disease, Western Denmark Heart Registry
- MeSH terms
- Aged, Aspirin, Coronary Artery Disease, Denmark, Diabetes Mellitus, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Registries, Risk Factors, Cohort Studies, Comorbidity, Coronary Angiography, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.